Product: Enablex (darifenacin) Extended Release Tablet, 15 mg per tablet.  Physician Sample 7 Tablets bottle, Rx only,  Mfd by:  Novartis Pharma Stein AG, Stein, Switzerland, NDC 0078-9420-07
Reason for recall: Failed Impurities/Degradation Specifications: unspecified degradation product
Recall initiated: 20130517
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated